Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.
about
How cell death shapes cancerPrognostic significance of bcl-2 and p53 expression in colorectal carcinoma.MTA1--a stress response protein: a master regulator of gene expression and cancer cell behavior.Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29.Targeting Nur77 translocation.The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.Pharmacogenomics of colorectal cancer prevention and treatment.High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival.The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.Apoptosis drives cancer cells proliferate and metastasize.Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy.
P2860
Q27021441-249C6A7E-E005-4719-81D6-C868D0E4F0DDQ34426903-64009976-10BE-4B79-8EDC-A040E1BA8D7DQ34573808-79306C1E-D5DA-4A94-8F3C-8850F4CD7E30Q34585908-72A988FF-9CA8-4C06-B4D6-74473D2DF1C2Q34588195-A864E31F-16C1-4424-9C74-6DA889C37872Q35689819-B5EFB2EF-5F92-46EC-AEB6-8055CE63636DQ36597059-409843E5-C23B-4E13-80B8-28FCCCADCB06Q36896177-6BD61D99-F008-4B01-8915-C99FB589D6A1Q38157864-F588A4A9-7CDB-49F7-B7D8-C9D9A2690942Q41122501-FFA1EE0F-530A-4892-AC6D-D6CFC6F6BB9BQ42914191-38240396-7F86-446D-A5AA-37B8A7727F99Q46181800-71DD9EE4-038A-47E1-8470-A65625DF492EQ54394304-072E8A1E-A05B-429D-9515-82E09B63EC92
P2860
Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evidence that the p53 negative ...... croarray study of 460 patients
@nl
Evidence that the p53 negative ...... roarray study of 460 patients.
@ast
Evidence that the p53 negative ...... roarray study of 460 patients.
@en
type
label
Evidence that the p53 negative ...... croarray study of 460 patients
@nl
Evidence that the p53 negative ...... roarray study of 460 patients.
@ast
Evidence that the p53 negative ...... roarray study of 460 patients.
@en
prefLabel
Evidence that the p53 negative ...... croarray study of 460 patients
@nl
Evidence that the p53 negative ...... roarray study of 460 patients.
@ast
Evidence that the p53 negative ...... roarray study of 460 patients.
@en
P2093
P2860
P356
P1476
Evidence that the p53 negative ...... roarray study of 460 patients.
@en
P2093
Duncan Scrimegour
John H Scholefield
Lindy G Durrant
Nicholas F S Watson
Zahra Madjd
P2860
P2888
P356
10.1186/1477-7819-3-47
P407
P577
2005-07-19T00:00:00Z
P5875
P6179
1036507096